Skip to main content

State Street Corp

SEC CIK
0000093751
Latest filing
Sep 22, 2026

VTGN holding history

Vistagen Therapeutics, Inc. in every 13F filed by State Street Corp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VTGN overviewAll 13F holders of VTGNFull Q2 2026 holdings

Shares (Q2 2026)
121,114
Value
$27.4K
% of portfolio
<0.1%
Quarters held
21
Since Q2 2021
Holdings of VTGN by State Street Corp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026121,114$27.4K<0.1%00.0%UnchangedHolders
Q1 2026121,114$69.2K<0.1%00.0%UnchangedHolders
Q4 2025121,114$80.2K<0.1%+24,256+25.0%AddedHolders
Q3 202596,858$343.8K<0.1%00.0%UnchangedHolders
Q2 202596,858$193.7K<0.1%00.0%UnchangedHolders
Q1 202596,858$242.1K<0.1%00.0%UnchangedHolders
Q4 202496,858$285.7K<0.1%+8,150+9.2%AddedHolders
Q3 202488,708$267.0K<0.1%00.0%UnchangedHolders
Q2 202488,708$308.7K<0.1%+5,000+6.0%AddedHolders
Q1 202483,708$442.0K<0.1%+34,200+69.1%AddedHolders
Q4 202349,508$254.5K<0.1%+24,044+94.4%AddedHolders
Q3 202325,464$133.4K<0.1%00.0%UnchangedHolders
Q2 202325,464$47.6K<0.1%−188,937−88.1%ReducedConverted for a 1-for-30 splitHolders
Q1 20236,432,023$802.1K<0.1%+269,252+4.4%AddedHolders
Q4 20226,162,771$634.8K<0.1%+530,705+9.4%AddedHolders
Q3 20225,632,066$857.0K<0.1%+1,736,668+44.6%AddedHolders
Q2 20223,895,398$3.43M<0.1%+285,558+7.9%AddedHolders
Q1 20223,609,840$4.48M<0.1%−4,990,394−58.0%ReducedHolders
Q4 20218,600,234$16.8M<0.1%+745,095+9.5%AddedHolders
Q3 20217,855,139$21.5M<0.1%+4,795,529+156.7%AddedHolders
Q2 20213,059,610$9.64M<0.1%+3,059,610NewHolders